SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
324Re your comment to MJ: <i>You are right on all counts and in principle<Ian@SI-8/11/2003
323You are right on all counts and in principle.keokalani'nui-8/11/2003
322>> Why can not be simple and strait forward release where anyone with littscaram(o)uche-8/10/2003
321OT (in part) Rick, <<This sort of release was THE sector standard, firstMiljenko Zuanic-8/10/2003
320>> I do not agree. << You're allowed. :-) I don't/didnscaram(o)uche-8/10/2003
319I do not agree. Few numbers will not compromise investigator right first to preMiljenko Zuanic-8/10/2003
318>> Although I am not happy about this non release of information...... <scaram(o)uche-8/10/2003
317Based on your numerical analysis it seems like a safe assumption that ALXN was cMadharry-8/10/2003
316<i>If alxn $10 before AHA, say within 3 weeks of meeting, I'll be runnIan@SI-8/8/2003
315WE, You are asking questions that none on street (or analyst) can answer at thiMiljenko Zuanic-8/8/2003
314Ian, Side effects was raised in a question. Bell basically said "no issuekeokalani'nui-8/8/2003
313I tried to add something intelligent to your post, but after a few hours I conclkeokalani'nui-8/8/2003
312Few thoughts and speculations on PIII PRIMO results: In PIIb key data are: a) Miljenko Zuanic-8/7/2003
311I don't recognize the name Pictet funds nor did I check to see whether or noIan@SI-8/7/2003
310Wilder, Looks like the Dow Jones reporter has the same impression as you - NoIan@SI-8/7/2003
309Erik, I think they were very close to meeting their primary endpoint. i.e. - Ian@SI-8/7/2003
308>>Why bother if < 6mos?>> The problem is that Alexion has not beIcebrg-8/7/2003
307Why bother if < 6mos? Personally I would want the FDA bother to approve a drkeokalani'nui-8/7/2003
306I believe a lot will depend on how the 6-months data look. If there indeed is a Icebrg-8/7/2003
305>>It prevents deaths - just not more than 30% of the expected CABG deaths keokalani'nui-8/7/2003
304Madharry, I was under the impression that the trial was over (in the sense thatIan@SI-8/6/2003
303Ice, Thanks. A very accurate article. I am still long. Shaken, but long. Ikeokalani'nui-8/6/2003
302Alexion Offers Early, Mixed Phase III Data For Heart Drug By Randall Osborne NIcebrg-8/6/2003
301listening to the conference call now- it sounds like the valve patients were onlMadharry-8/5/2003
300Doesn't seem to be much interest in ALXN so I won't pollute the thread wIan@SI-8/5/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News